Stimulant use under a prison treatment protocol for attention-deficit/hyperactivity disorder

Area of Science:

• Forensic Psychiatry
• Neurodevelopmental Disorders
• Correctional Healthcare

Background:

• Stimulant medications are primary treatments for attention-deficit/hyperactivity disorder (ADHD).
• High ADHD prevalence rates (9-45%) are reported in correctional settings, posing challenges for staff.
• Existing prevalence data may overestimate the actual need for stimulant treatment in incarcerated populations.

Purpose of the Study:

• To assess the actual need for stimulant treatment among male inmates in a correctional setting.
• To evaluate the feasibility of implementing a monitored protocol for stimulant prescription in prisons.
• To provide a more realistic estimate of stimulant treatment requirements in a forensic population.

Main Methods:

• A monitored protocol was implemented in the Massachusetts state prison system.
• Inclusion criteria required documented ADHD history, diagnosis, lack of response to non-stimulant treatments, and significant functional impairment.
• The study focused on male inmates undergoing evaluation for stimulant medication.

Main Results:

• Less than 1% of male inmates met the strict criteria for stimulant treatment.
• This rate is significantly lower than the commonly reported prevalence rates for ADHD in correctional facilities.
• The protocol highlighted specific, documented needs for intervention rather than broad prevalence.

Conclusions:

• The actual need for stimulant medication in male inmates may be considerably lower than previously suggested.
• Strict, monitored protocols are essential for appropriate stimulant prescription in correctional settings.
• Careful evaluation can mitigate potential challenges associated with stimulant use in forensic populations.